SEC Form 4 · accession 0001437749-17-002462
CAMBREX CORP · CBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Klosk
Officer — President & CEO · Director
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000820081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 10, 2017 | S | 49,266 | $52.624 | D | 109,062 | D | |
| Common StockF3 | Feb 10, 2017 | S | 1,912 | $53.355 | D | 107,150 | D | |
| Common StockF5 | Feb 13, 2017 | M | 12,000 | $5.72 | A | 119,150 | D | |
| Common StockF5,F4 | Feb 13, 2017 | S | 11,900 | $52.089 | D | 107,250 | D | |
| Common StockF5 | Feb 13, 2017 | S | 100 | $52.75 | D | 107,150 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $5.72 | Feb 13, 2017 | M | 12,000 | A | — | Oct 18, 2018 | Common Stock | 12,000 | 88,000 | D |
Explanation of responses
- F1Broker-assisted sale of which 38,936 shares sold were to cover the payment of withholding tax liability arising from the settlement of a performance share award granted on February 7, 2017
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.25 to $53.20 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.35 to $53.40 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.73 to $52.70 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4
- F5The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934
- F6The option representing a right to purchase 100,000 shares became exercisable in four equal installments beginning October 18, 2012, which was the first anniversary of the date on which the option was granted